Third-Party ESG Assurance (Limited vs Reasonable): What Pharma Needs in 2024 Third-Party ESG Assurance (Limited vs Reasonable): What Pharma Needs in 2024 As the pharmaceutical industry increasingly faces scrutiny over environmental, social, and governance (ESG) practices, understanding the nuances of ESG reporting assurance becomes critical. This comprehensive guide will walk you through the steps necessary to differentiate between limited and reasonable assurance levels, the ESG reporting frameworks available, and the specific requirements for compliance in the United States. Step 1: Understanding ESG Reporting Frameworks The first step in ensuring that your organization is complying with ESG reporting standards is to…

Supplier ESG Scorecards for Pharma: Contract Clauses and Verification Strategy in 2023 Supplier ESG Scorecards for Pharma: Contract Clauses and Verification Strategy in 2023 In an increasingly regulated environment, pharmaceutical companies must ensure that their supply chains align with environmental, social, and governance (ESG) standards. This comprehensive step-by-step guide outlines the process of developing effective Supplier ESG Scorecards, focusing on contract clauses and verification strategies relevant to the pharmaceutical industry in the United States. This tutorial aims to lead professionals in Environmental Health and Safety (EHS), Regulatory Affairs, Quality Assurance (QA), and Sustainability/ESG through critical actions and documentation necessary for…

ESG Risk Register for Global Pharma Supply Chains: Practical Template for 2023 ESG Risk Register for Global Pharma Supply Chains: Practical Template for 2023 As global environmental regulations tighten and stakeholders become increasingly concerned about environmental, social, and governance (ESG) issues, pharmaceutical companies must establish robust ESG reporting frameworks. This article provides a comprehensive step-by-step tutorial on creating an ESG Risk Register tailored for global pharma supply chains, ensuring compliance with prominent ESG reporting standards such as GRI, SASB, and CSRD. Through this guide, professionals in regulatory affairs, quality assurance, and sustainability can develop effective tools for managing risks and…

AI-Based ESG Data Reporting: Validation and Controls to Avoid Greenwashing Risk in 2023 AI-Based ESG Data Reporting: Validation and Controls to Avoid Greenwashing Risk in 2023 As regulatory requirements evolve rapidly, organizations in the pharmaceutical industry must prioritize robust Environmental, Social, and Governance (ESG) data reporting frameworks. The rise of artificial intelligence (AI) in ESG reporting presents unique opportunities and challenges. This guide provides a step-by-step approach for pharmaceutical professionals to implement AI-based ESG reporting systems, ensuring compliance and avoiding the pitfalls of greenwashing. Step 1: Understanding ESG Reporting Standards Before adopting AI solutions for ESG reporting, it is crucial…

How ESG Metrics Influence Customer Audits and Tender Eligibility in 2023 How ESG Metrics Influence Customer Audits and Tender Eligibility in 2023 In an age where environmental, social, and governance (ESG) practices are pivotal to business success, understanding how these metrics impact customer audits and tender eligibility is essential for pharmaceutical companies. This comprehensive tutorial provides a structured framework guiding you through the regulatory landscape that shapes ESG reporting, ensuring compliance with the latest standards such as the EU’s CSRD, GRI, SASB, and SEC climate disclosure requirements. By following the steps outlined below, pharmaceutical professionals can adapt their strategies effectively,…